- Home
- EML vs MGX Comparison
EML vs MGX Comparison
Compare EML & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- MGX
- Stock Information
- Founded
- EML 1858
- MGX 2018
- Country
- EML United States
- MGX United States
- Employees
- EML N/A
- MGX N/A
- Industry
- EML Industrial Machinery/Components
- MGX
- Sector
- EML Consumer Discretionary
- MGX
- Exchange
- EML Nasdaq
- MGX NYSE
- Market Cap
- EML 191.3M
- MGX 150.1M
- IPO Year
- EML N/A
- MGX 2024
- Fundamental
- Price
- EML $26.66
- MGX $2.76
- Analyst Decision
- EML
- MGX Strong Buy
- Analyst Count
- EML 0
- MGX 7
- Target Price
- EML N/A
- MGX $16.67
- AVG Volume (30 Days)
- EML 11.4K
- MGX 1.3M
- Earning Date
- EML 11-01-2024
- MGX 02-12-2025
- Dividend Yield
- EML 1.66%
- MGX N/A
- EPS Growth
- EML N/A
- MGX N/A
- EPS
- EML N/A
- MGX N/A
- Revenue
- EML $284,461,286.00
- MGX $55,080,000.00
- Revenue This Year
- EML N/A
- MGX $16.91
- Revenue Next Year
- EML N/A
- MGX N/A
- P/E Ratio
- EML $13.23
- MGX N/A
- Revenue Growth
- EML 7.70
- MGX 45.13
- 52 Week Low
- EML $22.63
- MGX $1.61
- 52 Week High
- EML $35.78
- MGX $12.74
- Technical
- Relative Strength Index (RSI)
- EML 43.93
- MGX 41.75
- Support Level
- EML $25.31
- MGX $2.96
- Resistance Level
- EML $26.90
- MGX $4.06
- Average True Range (ATR)
- EML 0.69
- MGX 0.37
- MACD
- EML 0.00
- MGX -0.16
- Stochastic Oscillator
- EML 54.66
- MGX 5.20
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).